Apelin receptor early endogenous ligand (APELA)

Homo sapiens — UniProt P0DMC3

Gene: APELAHomo sapiensSwissProt reviewed

About Apelin receptor early endogenous ligand

Apelin receptor early endogenous ligand (APELA) is a protein from Homo sapiens identified by UniProt accession P0DMC3, 54 residues long. MolForge cross-references it against 0 known binders and 93 disease associations.

Target properties

Protein nameApelin receptor early endogenous ligand
UniProt accessionP0DMC3
GeneAPELA
OrganismHomo sapiens
Length54 residues
Molecular weight—
EC numbers—
Target classUNCLASSIFIED
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (93)

Diseases linked to this target (Open Targets).

  • attention deficit hyperactivity disorder · score 0.28
  • glioblastoma multiforme · score 0.08
  • neoplasm · score 0.06
  • myocardial infarction · score 0.06
  • cancer · score 0.04
  • Ischemic stroke · score 0.04
  • atrial fibrillation · score 0.03
  • chronic obstructive pulmonary disease · score 0.03
  • preeclampsia · score 0.03
  • non-small cell lung carcinoma · score 0.02

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-P0DMC3-F1alphafoldPREDICTED72.54—

Amino-acid sequence (54 residues)

MRFQQFLFAF FIFIMSLLLI SGQRPVNLTM RRKLRKHNCL QRRCMPLHSR VPFP

Explore Apelin receptor early endogenous ligand with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtP0DMC3
GeneAPELA
OrganismHomo sapiens
Length54
Binders0
Diseases93
View on UniProt